Skip to main content
Erschienen in: Calcified Tissue International 4/2005

01.04.2005

Increased Incidence of Vertebral Fracture in Older Female Hemodialyzed Patients with Type 2 Diabetes Mellitus

verfasst von: M. Inaba, S. Okuno, Y. Kumeda, T. Yamakawa, E. Ishimura, Y. Nishizawa

Erschienen in: Calcified Tissue International | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Bone disease in hemodialysis (HD) patients with type 2 diabetes mellitus (DM) is characterized by low bone turnover (Inaba M, et al. Am J Kidney Dis 2002; 39:1261-1269), although their bone quality is yet to be determined. The present study was designed to examine whether the prevalence of vertebral fracture in female HD patients with type 2 DM, age 65 years and older, might be increased, and the relation of this fracture to bone mineral density (BMD) determined by dual X-ray absorptiometry (DXA), since few data are available on the effect of DM on bone strength at lumbar spine. The prevalence of vertebral fracture in type 2 DM HD patients was 32.3%, which was greater than that of non-DM HD patients (13.3%) when adjusted for age and HD duration. Logistic regression analysis elucidated the presence of DM and age as independent risk factors for an increased prevalence of vertebral fracture in HD patients. In non-DM HD patients, those with vertebral fracture showed age significantly higher and BMD in either lumbar spine or distal one third of radius significantly lower than the respective value in those without fracture. However, in DM HD patients, neither BMD in lumbar spine nor distal one third of radius was significantly lower in those with vertebral fracture than in those without. Furthermore, age did not differ significantly between DM HD patients with and without fracture. In conclusion, female type 2 DM HD patients, age 65 years and older, showed significantly higher incidence of vertebral fracture than non-DM HD patients. Although age and low BMD emerged as independent risk factors for vertebral fracture in non-DM HD patients, those factors failed to be a risk factor in DM HD patients, suggesting that BMD determined by DXA might not be reliable in assessing bone strength in DM HD patients.
Literatur
1.
Zurück zum Zitat Inaba, M, Ishimura, E (2002) “Secondary osteoporosis” In: Moril, H, Nishizawa, Y, Masry, SG, (editors), Calcium in Internal Medicine, Springer-Verlag, London, pp 347–360 Inaba, M, Ishimura, E (2002) “Secondary osteoporosis” In: Moril, H, Nishizawa, Y, Masry, SG, (editors), Calcium in Internal Medicine, Springer-Verlag, London, pp 347–360
2.
Zurück zum Zitat Rico, H, Hernandez, ER, Cabranes, JA, Gomez-Castresana, F 1989Suggestion of a deficient osteoblastic function in diabetes mellitus. The possible cause of osteopenia in diabeticsCalcif Tissue Int457173CrossRef Rico, H, Hernandez, ER, Cabranes, JA, Gomez-Castresana, F 1989Suggestion of a deficient osteoblastic function in diabetes mellitus. The possible cause of osteopenia in diabeticsCalcif Tissue Int457173CrossRef
3.
Zurück zum Zitat Bouillon, R, Bex, M, Herck, EV, Laureys, J, Dooms, L, Lesaffre, E, Ravussin, 1995Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitusJ Clin Endocrinol Metab8011941202PubMed Bouillon, R, Bex, M, Herck, EV, Laureys, J, Dooms, L, Lesaffre, E, Ravussin,  1995Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitusJ Clin Endocrinol Metab8011941202PubMed
4.
Zurück zum Zitat Krakauer, JC, McKenna, MJ, Buderer, NF, Rao, DS, Whitehouse, FW, Parfitt, AM 1995Bone loss and bone turnover in diabetesDiabetes44775782CrossRef Krakauer, JC, McKenna, MJ, Buderer, NF, Rao, DS, Whitehouse, FW, Parfitt, AM 1995Bone loss and bone turnover in diabetesDiabetes44775782CrossRef
5.
Zurück zum Zitat Inaba, M, Nagasue, K, Okuno, S, Ueda, M, Kumeda, Y, Imanishi, Y, Shoji, T, Ishimura, E, Ohta, T, Nakatani, T, Kim, M, Nishizawa, Y 2002Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitusAm J Kidney Dis3912611269CrossRef Inaba, M, Nagasue, K, Okuno, S, Ueda, M, Kumeda, Y, Imanishi, Y, Shoji, T, Ishimura, E, Ohta, T, Nakatani, T, Kim, M, Nishizawa, Y 2002Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitusAm J Kidney Dis3912611269CrossRef
6.
Zurück zum Zitat Inaba, M, Okuno, S, Nagasue, K, Otoshi, T, Kurioka, Y, Maekawa, K, Kumeda, Y, Imanishi, Y, Ishimura, E, Ohta, T, Morii, H, Kim, M, Nishizawa, Y 2001Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patientsAm J Kidney Dis38S139142CrossRef Inaba, M, Okuno, S, Nagasue, K, Otoshi, T, Kurioka, Y, Maekawa, K, Kumeda, Y, Imanishi, Y, Ishimura, E, Ohta, T, Morii, H, Kim, M, Nishizawa, Y 2001Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patientsAm J Kidney Dis38S139142CrossRef
7.
Zurück zum Zitat Inaba, M, Nishizawa, Y, Mita, K, Kumeda, Y, Emoto, M, Kawagishi, T, Ishimura, E, Nakatsuka, K, Shioi, A, Morii, H 1999Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetesOsteoporos Int9525531CrossRef Inaba, M, Nishizawa, Y, Mita, K, Kumeda, Y, Emoto, M, Kawagishi, T, Ishimura, E, Nakatsuka, K, Shioi, A, Morii, H 1999Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetesOsteoporos Int9525531CrossRef
8.
Zurück zum Zitat Kawagishi, T, Morii, H, Nakatsuka, K, Sasao, K, Kawasaki, K, Miki, T, Nishizawa, Y 1991Parathyroid hormone secretion in diabetes mellitusContrib Nephrol9021722CrossRef Kawagishi, T, Morii, H, Nakatsuka, K, Sasao, K, Kawasaki, K, Miki, T, Nishizawa, Y 1991Parathyroid hormone secretion in diabetes mellitusContrib Nephrol9021722CrossRef
9.
Zurück zum Zitat Schwartz, AV, Sellmeyer, DE, Ensrud, KE, Cauley, JA, Tabor, HK, Schreiner, PJ, Jamal, SA, Black, DM, Cummings, SR 2001Older women with diabetes have an increased risk of fracture: a prospective studyJ Clin Endocrinol Metab863238CrossRef Schwartz, AV, Sellmeyer, DE, Ensrud, KE, Cauley, JA, Tabor, HK, Schreiner, PJ, Jamal, SA, Black, DM, Cummings, SR 2001Older women with diabetes have an increased risk of fracture: a prospective studyJ Clin Endocrinol Metab863238CrossRef
10.
Zurück zum Zitat Atsumi, K, Kushida, K, Yamazaki, K, Shimizu, S, Ohmura, A, Inoue, T 1999Risk factors for vertebral fractures in renal osteodystrophyAm J Kidney Dis33287293CrossRef Atsumi, K, Kushida, K, Yamazaki, K, Shimizu, S, Ohmura, A, Inoue, T 1999Risk factors for vertebral fractures in renal osteodystrophyAm J Kidney Dis33287293CrossRef
11.
Zurück zum Zitat Coco, M, Rush, H 2000Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormoneAm J Kidney Dis36:11151121CrossRef Coco, M, Rush, H 2000Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormoneAm J Kidney Dis36:11151121CrossRef
12.
Zurück zum Zitat Piraino, B, Chen, T, Cooperstein, L, Segre, G, Puschett, J 1988Fractures and vertebral bone mineral density in patients with renal osteodystrophyClin Nephrol305762PubMed Piraino, B, Chen, T, Cooperstein, L, Segre, G, Puschett, J 1988Fractures and vertebral bone mineral density in patients with renal osteodystrophyClin Nephrol305762PubMed
13.
Zurück zum Zitat Nelson, DA, Jacober, SJ 2001Editorial: Why do older women with diabetes have an increased fracture risk?J Clin Endocrinol Metab862931CrossRef Nelson, DA, Jacober, SJ 2001Editorial: Why do older women with diabetes have an increased fracture risk?J Clin Endocrinol Metab862931CrossRef
14.
Zurück zum Zitat WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva, WHO WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva, WHO
15.
Zurück zum Zitat Schaffler, MR 2003Role of bone turnover in microdamageOsteoporos Int14S73S80CrossRef Schaffler, MR 2003Role of bone turnover in microdamageOsteoporos Int14S73S80CrossRef
16.
Zurück zum Zitat American Diabetes Association1998Mellitus TECotDacoD. Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care21S5S22 American Diabetes Association1998Mellitus TECotDacoD. Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care21S5S22
17.
Zurück zum Zitat Kumeda, Y, Inaba, M, Tahara, H, Kurioka, Y, Ishikawa, T, Morii, H, Nishizawa, Y 2000Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidismJ Clin Endocrinol Metab8541574161PubMed Kumeda, Y, Inaba, M, Tahara, H, Kurioka, Y, Ishikawa, T, Morii, H, Nishizawa, Y 2000Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidismJ Clin Endocrinol Metab8541574161PubMed
18.
Zurück zum Zitat Ishimura, E, Okuno, S, Kim, M, Yamamoto, T, Izumotani, T, Otoshi, T, Shoji, T, Inaba, M, Nishizawa, Y 2001Increasing body fat mass in the first tear of hemodialysisJ Am Soc Nephrol1219211926PubMed Ishimura, E, Okuno, S, Kim, M, Yamamoto, T, Izumotani, T, Otoshi, T, Shoji, T, Inaba, M, Nishizawa, Y 2001Increasing body fat mass in the first tear of hemodialysisJ Am Soc Nephrol1219211926PubMed
19.
Zurück zum Zitat Ueda, M, Inaba, M, Okuno, S, Nagasue, K, Kitatani, K, Ishimura, E, Shimizu, M, Miki, T, Kim, M, Nishizawa, Y 2002Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patientsAm J Kidney Dis40802809CrossRef Ueda, M, Inaba, M, Okuno, S, Nagasue, K, Kitatani, K, Ishimura, E, Shimizu, M, Miki, T, Kim, M, Nishizawa, Y 2002Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patientsAm J Kidney Dis40802809CrossRef
20.
Zurück zum Zitat Cummings, SR, Black, DM, Nevitt, MC, Browner, W, Cauley, J, Ensrud, K, Genant, HK, Palermo, L, Scott, J, Vogt, TM 1993Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research GroupLancet.3417275CrossRef Cummings, SR, Black, DM, Nevitt, MC, Browner, W, Cauley, J, Ensrud, K, Genant, HK, Palermo, L, Scott, J, Vogt, TM 1993Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research GroupLancet.3417275CrossRef
21.
Zurück zum Zitat Inaba, M, Terada, M, Koyama, H, Yoshida, O, Ishimura, E, Kawagishi, T, Okuno, Y, Nishizawa, Y, Otani, S, Morii, H 1995Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cellsJ Bone Miner Res1010501060CrossRef Inaba, M, Terada, M, Koyama, H, Yoshida, O, Ishimura, E, Kawagishi, T, Okuno, Y, Nishizawa, Y, Otani, S, Morii, H 1995Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cellsJ Bone Miner Res1010501060CrossRef
22.
Zurück zum Zitat Terada, M, Inaba, M, Yano, Y, Hasuma, T, Nishizawa, Y, Morii, H, Otani, S 1998Growth-inhibitory effect of a high glucose concentration on osteoblast-like cellsBone221723CrossRef Terada, M, Inaba, M, Yano, Y, Hasuma, T, Nishizawa, Y, Morii, H, Otani, S 1998Growth-inhibitory effect of a high glucose concentration on osteoblast-like cellsBone221723CrossRef
23.
Zurück zum Zitat Inaba, M, Terada, M, Nishizawa, Y, Shioi, A, Ishimura, E, Otani, S, Morii, H 1999Protective effect of aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of polyol pathway in bone metabolismMetabolism48904909CrossRef Inaba, M, Terada, M, Nishizawa, Y, Shioi, A, Ishimura, E, Otani, S, Morii, H 1999Protective effect of aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of polyol pathway in bone metabolismMetabolism48904909CrossRef
24.
Zurück zum Zitat Inaba, M, Nishizawa, Y, Shioi, A, Morii, H 1997Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathwayOsteoporos Int 7.S209S212CrossRef Inaba, M, Nishizawa, Y, Shioi, A, Morii, H 1997Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathwayOsteoporos Int 7.S209S212CrossRef
25.
Zurück zum Zitat Vogt, MT, Cauley, JA, Kuller, LH, Nevitt, MC 1977Bone mineral density and blood flow to the lower extremities: The Study of Osteoporotic FracturesJ Bone Miner Res12283289CrossRef Vogt, MT, Cauley, JA, Kuller, LH, Nevitt, MC 1977Bone mineral density and blood flow to the lower extremities: The Study of Osteoporotic FracturesJ Bone Miner Res12283289CrossRef
26.
Zurück zum Zitat Piepkorn, B, Kann, P, Forst, T, Andreas, J, Pfutzner, A, Beyer, J 1997Bone mineral density and bone metabolism in diabetes mellitusHorm Metab Res29584591CrossRef Piepkorn, B, Kann, P, Forst, T, Andreas, J, Pfutzner, A, Beyer, J 1997Bone mineral density and bone metabolism in diabetes mellitusHorm Metab Res29584591CrossRef
27.
Zurück zum Zitat Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2001Diabetes and risk of fractureDiabetes Care2411981203CrossRef Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2001Diabetes and risk of fractureDiabetes Care2411981203CrossRef
28.
Zurück zum Zitat Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2000Diabetes and risk of fracture: the Blue Mountains Eye StudyDiabetes Care2411982003CrossRef Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2000Diabetes and risk of fracture: the Blue Mountains Eye StudyDiabetes Care2411982003CrossRef
29.
Zurück zum Zitat Nicodemus, K, Folsom, AR 2001Type 1 and type 2 diabetes and incident hip fracture in postmenopausal womenDiabetes Care2411921197CrossRef Nicodemus, K, Folsom, AR 2001Type 1 and type 2 diabetes and incident hip fracture in postmenopausal womenDiabetes Care2411921197CrossRef
30.
Zurück zum Zitat Chau, DL, Edelman, SV 2002Osteoporosis and DiabetesClin Diabetes20153157CrossRef Chau, DL, Edelman, SV 2002Osteoporosis and DiabetesClin Diabetes20153157CrossRef
Metadaten
Titel
Increased Incidence of Vertebral Fracture in Older Female Hemodialyzed Patients with Type 2 Diabetes Mellitus
verfasst von
M. Inaba
S. Okuno
Y. Kumeda
T. Yamakawa
E. Ishimura
Y. Nishizawa
Publikationsdatum
01.04.2005
Erschienen in
Calcified Tissue International / Ausgabe 4/2005
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0094-0

Weitere Artikel der Ausgabe 4/2005

Calcified Tissue International 4/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.